Table 2.
Indications | Essential and conditional examinations/investigations | Adaptation to special setting and situations |
---|---|---|
Reported symptoms: fatigue (or exhaustion or asthenia or weakness) and or dyspnoea, cough, chest pain17,52,54,58,59,70 |
In alternative or addition:
|
|
Impaired health-related quality of life57,59,62 |
|
|
Impaired ADL/functional status52,54,57,59,61,62 |
In alternative or addition:
|
|
Impaired exercise capacity52,54,57–59,62,68,71–74 |
In alternative or addition:
|
|
Presence of comorbid conditions, including COPD, asthma, bronchiectasis, pulmonary fibrosis, pulmonary hypertension, cardiac impairment, autonomic nervous system disfunction52,57 |
|
|
Impaired pulmonary function23,36,37,57,58,73–76 |
|
|
Impaired blood gas analysis and/or exercise-induced desaturation52–54,57,59,69 |
|
|
Reported anxiety and depression77 |
In alternative or addition:
|
|
COPD = chronic obstructive pulmonary disease; PEF = peak expiratory flow; ADL = activity of daily life.